Market Cap (In USD)
41.24 Billion
Revenue (In USD)
15.44 Billion
Net Income (In USD)
1.66 Billion
Avg. Volume
17.28 Million
- Currency
- USD
- Country
- Consumer Defensive
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17.67-24.46
- PE
- -
- EPS
- -
- Beta Value
- 1.257601
- ISIN
- US49177J1025
- CUSIP
- 49177J102
- CIK
- 1944048
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Mr. Thibaut Mongon
- Employee Count
- -
- Website
- https://www.kenvue.com
- Ipo Date
- 2023-05-04
- Details
- Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
More Stocks
-
IREDA
-
6902DENSO Corporation
6902
-
MTECMade Tech Group Plc
MTEC
-
EBQEbiquity plc
EBQ
-
RGLS
-
EXMGFExcelsior Mining Corp.
EXMGF
-
PANTHPANTH INFINITY LIMITED
PANTH
-
4626